Filter your results
- 3
- 1
- 4
- 4
- 2
- 2
- 4
- 4
- 4
- 3
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 3
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLLBlood, 2015, 126 (18), pp.2110--2117. ⟨10.1182/blood-2015-05-647578⟩
Journal articles
hal-01263113v1
|
||
Central Nervous System Involvement in Chronic Lymphocytic Leukemia: Diagnosis and Treatment in a Retrospective Cohort of Thirty PatientsBlood, 2015, 126 (23), pp.2948
Journal articles
hal-01290433v1
|
|||
Evaluating abbreviated induction with fludarabine, cyclophosphamide, and dose-dense rituximab in elderly patients with chronic lymphocytic leukemiaLeukemia & lymphoma, 2016, 57 (2), pp.328--334. ⟨10.3109/10428194.2015.1063139⟩
Journal articles
hal-01272930v1
|
|||
|
ISOLD: A New Highly Sensitive Interleukin Score for Intraocular Lymphoma DiagnosisOphthalmology: Journal of The American Academy of Ophthalmology, 2016, 123 (7), pp.1626-1628. ⟨10.1016/j.ophtha.2016.01.037⟩
Journal articles
hal-01290416v1
|